Challenges of implementing PV processes in Mena region
*Corresponding Author:
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Pharmacovigilance has received much attention in MENA region countries recently due to the development of new regulations. Only approximately half of Arab countries are official members of the World Health Organization (WHO) Collaborating Centre for International Drug Monitoring. Countries such as Saudi Arabia, Morocco, Tunisia, Egypt, and Jordan are considered to be relatively advanced pharmacovigilance countries, whereas other countries such as Libya, Yemen, and Palestine remain in the very early stages of implementing and developing pharmacovigilance systems.
Countries such as Somalia, Djibouti, Mauritania, have no pharmacovigilance system or culture.
